The expression of CD47 and PD-L1 was evaluated in three human BC cell lines—SKBR-3, MCF-7, and MDA.MB.231—representing HER2-positive, luminal, and basal-like BC subtypes, respectively. This evidence concerns the gene ERBB2 and breast cancer.